Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02539342 · ClinicalTrials.gov registry record · Phase 3
Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy
A Phase 3 study, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT02539342: Clinical Trial Phase 3 study, sponsored by Medical College of Wisconsin.
NCT02539342 is a Phase 3 study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 1 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02539342, a Phase 3 study, was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the administration of Caphosol rinse, at the start of chemotherapy, will prevent the development of mucositis (greater than or equal to grade 2 in children, adolescents and young adults. This is a randomized, controlled trial.
Primary Outcome
The development of Mucositis Grade \>/= 2 in children receiving chemotherapy as evaluated using CTCAE 4.0
Interventions
- DRUG Caphosol
- DRUG Biotene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-03-02 |
| Phase | Phase 3 |
Why NCT02539342 stopped before completion
NCT02539342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Caphosol is the first listed.
NCT02539342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02539342 about?
NCT02539342 is a clinical study titled "Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy". The purpose of this study is to determine if the administration of Caphosol rinse, at the start of chemotherapy, will prevent the development of mucositis (greater than or equal to grade 2 in children, adolescents and young adults. This is a randomized, controlled trial.
What is the current status of trial NCT02539342?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2016-10. Estimated completion is 2017-03-02.
What interventions are being tested in trial NCT02539342?
The interventions under investigation include: Caphosol (DRUG), Biotene (DRUG).
Who is sponsoring clinical trial NCT02539342?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02539342's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia